-
First Republic, Novartis and Pinterest rose premarket; Caterpillar fell
-
Citi Reiterates Buy Rating on Novartis (NVS)
-
UPDATE: Citi Downgrades Eli Lilly (LLY) to Neutral
-
Citi Upgrades Novartis (NVS) to Buy
-
GlaxoSmithKline (GSK) Acquires Novartis' (NVS) 36.5% Stake in Consumer Healthcare Joint Venture for $13B
-
Pre-Open Movers 10/30: (CAA) (ADMS) (DYN) Higher; (PSTI) (CTB) (CENX) Lower (more...)
-
UPDATE: GlaxoSmithKline (GSK) Said Exploring Takeover of United Therapeutics (UTHR), Gilead (GILD) Seen as Front-runner - Standard
-
PlacementTracker Publishes Q1 2017 Private Placement Market League Tables
-
Unusual 11 Mid-Day Movers 1/23: (EGLT) (ARRY) (NVRO) Higher; (LF) (MCP) (OCN) Lower
-
Maverick Capital Shows New Stakes in AerCap (AER), Allscripts-Misys (MDRX), Ctrip.com (CTRP), Twenty-First Century Fox (FOXA)
-
Notable Analyst Rating Changes 09/16: (HUN) (BMY) (BX) Upgraded; (NVS) (PXD) (DSX) Downgraded
-
Citi Upgrades Novartis (NVS) to Buy
-
Streetinsider.com's Hot Lunchtime Reads 01/18: (NCLH) (AAPL) (COF) (C) (CVX)
-
Notable Analyst Rating Changes 09/17: (TSLA) (NVS) (MCO) Upgraded; (CYS) (CLF) (AKS) Downgraded
-
Mylan (MYL) is No Generic When it Comes to Growth Potential - Barron's
-
Active equity option families in first 40-minutes of trading according to Track Data are: C BAC NVS BIDU
-
Citi Maintains a 'Buy' Rating on Alcon (ACL); First Look - Strong 2Q
-
Citi Maintains a 'Buy' on Alcon Inc (ACL); Independent Directors Make A Compelling Case
-
UPDATE - Citi Upgrades Alcon (ACL) to Buy; Recent Downward Move Creates Opportunity
-
Acorda (ACOR) Ticks Higher On New "Hold" Rating Which Discounts M&A Talk
-
Citi Upgrades Novartis (NVS) to Buy After-Hours
-
Swine Flu Stocks Higher After China Becomes 1st Country To Issue Mass H1N1 Inoculation
-
Top 10 News Items 8/31-9/4: Unemployment Rate Soars to 9.7%; Gold Rallies as Investors Hunker Down; Citi Shareholders Approve Increase in Authorized Shares
-
A Competing Bid for Crucell NV (CRXL)?
-
David Moenning's Daily State of the Markets: 10/16
-
Notable Analyst Rating Changes 9/11: NVS, TSN, ALB Upgraded; LEH, NVDA, RAI, KNXA Downgraded
-
Goldman Sachs Upgrades Novartis AG (NVS) to Buy
-
Citi Assumes Coverage on Ophthalmology Names - ACL, AGN, COO and EYE
-
Notable Mergers and Acquisitions of the Day 4/7 (YHOO/MSFT, NVS/ACL, DFS/C)

